These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 21175792

  • 1. Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection.
    Yoon H, Kim N, Kim JY, Park SY, Park JH, Jung HC, Song IS.
    J Gastroenterol Hepatol; 2011 Jan; 26(1):44-8. PubMed ID: 21175792
    [Abstract] [Full Text] [Related]

  • 2. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication.
    Kim MN, Kim N, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song IS.
    Helicobacter; 2008 Aug; 13(4):261-8. PubMed ID: 18665934
    [Abstract] [Full Text] [Related]

  • 3. Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea.
    Kang KK, Lee DH, Oh DH, Yoon H, Shin CM, Park YS, Kim N, Jung HC.
    World J Gastroenterol; 2014 Jun 14; 20(22):6932-8. PubMed ID: 24944485
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection.
    Du YQ, Su T, Fan JG, Lu YX, Zheng P, Li XH, Guo CY, Xu P, Gong YF, Li ZS.
    World J Gastroenterol; 2012 Nov 21; 18(43):6302-7. PubMed ID: 23180952
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication.
    Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N.
    World J Gastroenterol; 2015 May 14; 21(18):5568-74. PubMed ID: 25987781
    [Abstract] [Full Text] [Related]

  • 6. Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.
    Yoon H, Kim N, Lee BH, Hwang TJ, Lee DH, Park YS, Nam RH, Jung HC, Song IS.
    Helicobacter; 2009 Oct 14; 14(5):77-85. PubMed ID: 19751431
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
    Tongtawee T, Dechsukhum C, Leeanansaksiri W, Kaewpitoon S, Kaewpitoon N, Loyd RA, Matrakool L, Panpimanmas S.
    Asian Pac J Cancer Prev; 2015 Oct 14; 16(12):4885-90. PubMed ID: 26163609
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.
    Kim MS, Kim N, Kim SE, Jo HJ, Shin CM, Park YS, Lee DH.
    BMC Gastroenterol; 2013 Sep 19; 13():138. PubMed ID: 24050512
    [Abstract] [Full Text] [Related]

  • 10. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
    Grgov S, Tasić T, Radovanović-Dinić B, Benedeto-Stojanov D.
    Vojnosanit Pregl; 2016 Nov 19; 73(11):1044-9. PubMed ID: 29328644
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.
    Cheon JH, Kim N, Lee DH, Kim JM, Kim JS, Jung HC, Song IS.
    Helicobacter; 2006 Feb 19; 11(1):46-51. PubMed ID: 16423089
    [Abstract] [Full Text] [Related]

  • 12. Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy.
    Kim SE, Park MI, Park SJ, Moon W, Choi YJ, Cheon JH, Kwon HJ, Ku KH, Yoo CH, Kim JH, Lee GW, Song SE.
    Korean J Intern Med; 2015 Nov 19; 30(6):801-7. PubMed ID: 26552455
    [Abstract] [Full Text] [Related]

  • 13. Pretreatment with Lactobacillus- and Bifidobacterium-containing yogurt can improve the efficacy of quadruple therapy in eradicating residual Helicobacter pylori infection after failed triple therapy.
    Sheu BS, Cheng HC, Kao AW, Wang ST, Yang YJ, Yang HB, Wu JJ.
    Am J Clin Nutr; 2006 Apr 19; 83(4):864-9. PubMed ID: 16600940
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomized trial on 14 versus 7 days of esomeprazole, moxifloxacin, and amoxicillin for second-line or rescue treatment of Helicobacter pylori infection.
    Miehlke S, Krasz S, Schneider-Brachert W, Kuhlisch E, Berning M, Madisch A, Laass MW, Neumeyer M, Jebens C, Zekorn C, Knoth H, Vieth M, Stolte M, Lehn N, Morgner A.
    Helicobacter; 2011 Dec 19; 16(6):420-6. PubMed ID: 22059392
    [Abstract] [Full Text] [Related]

  • 16. Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.
    Ciccaglione AF, Cellini L, Grossi L, Marzio L.
    World J Gastroenterol; 2012 Aug 28; 18(32):4386-90. PubMed ID: 22969203
    [Abstract] [Full Text] [Related]

  • 17. Helicobacter pylori eradication: sequential therapy and Lactobacillus reuteri supplementation.
    Efrati C, Nicolini G, Cannaviello C, O'Sed NP, Valabrega S.
    World J Gastroenterol; 2012 Nov 21; 18(43):6250-4. PubMed ID: 23180945
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
    Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N.
    World J Gastroenterol; 2015 Apr 28; 21(16):5032-8. PubMed ID: 25945019
    [Abstract] [Full Text] [Related]

  • 19. Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments.
    Gisbert JP, Romano M, Molina-Infante J, Lucendo AJ, Medina E, Modolell I, Rodríguez-Tellez M, Gomez B, Barrio J, Perona M, Ortuño J, Ariño I, Domínguez-Muñoz JE, Perez-Aisa Á, Bermejo F, Domínguez JL, Almela P, Gomez-Camarero J, Millastre J, Martin-Noguerol E, Gravina AG, Martorano M, Miranda A, Federico A, Fernandez-Bermejo M, Angueira T, Ferrer-Barcelo L, Fernández N, Marín AC, McNicholl AG.
    Dig Liver Dis; 2015 Feb 28; 47(2):108-13. PubMed ID: 25454706
    [Abstract] [Full Text] [Related]

  • 20. Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection.
    Kiliç ZM, Köksal AS, Cakal B, Nadir I, Ozin YO, Kuran S, Sahin B.
    Dig Dis Sci; 2008 Dec 28; 53(12):3133-7. PubMed ID: 18465244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.